FMC (FMC) and Corteva (CTVA) announced a co-exclusive strategic supply and license agreement that will expand access to FMC’s rimisoxafen technology across North and South America corn and soybean markets. This collaboration will enable more growers across the Americas to control herbicide-resistant weeds, including Amaranthus species with this dual mode of action herbicide technology. Under the terms of the agreement, which extends through the next decade, FMC retains all rights of ownership to rimisoxafen and will supply Corteva with the active ingredient. Both companies will develop and commercialize their own exclusive premix formulations for the corn and soybean markets across North and South America, while FMC will continue to develop additional rimisoxafen-based products for other crops and geographies globally. Corteva will make an initial prepurchase payment of $200 million USD for product to be supplied by FMC. Together, both companies are committed to ensuring broad availability of this innovative technology and rapid adoption, supporting growers with durable weed management solutions for years to come. Additional terms of the agreement were not disclosed.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
